Press Releases July 21, 2026 09:00 AM

Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026

Stereotaxis schedules August 11 release of Q2 2026 financial results with investor webcast and conference call.

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
STXS

Stereotaxis, a leader in surgical robotics for minimally invasive endovascular procedures, announced that it will report its financial results for the second quarter of 2026 on August 11, 2026, following the close of U.S. markets. The company will host a conference call and webcast to discuss the results and corporate updates.

Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026
STXS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • The company will release Q2 2026 financial results on August 11, 2026 after market close.
  • A conference call and webcast will be held to discuss the financial results and corporate developments.
  • Stereotaxis is recognized as a pioneer in surgical robotics, with technology used globally in more than 150,000 patients.

ST. LOUIS, July 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026 second quarter on Tuesday, August 11, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. ET that day to discuss the Company’s results and corporate developments.

What:Stereotaxis second quarter 2026 financial results conference call  When:Tuesday, August 11, 2026, at 4:30 p.m. ET (1:30 p.m. PT)  Dial In Number:To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (International) and give the participant pass code 4404741.  Webcast:To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/.  Call Replay:A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here.  

About Stereotaxis
Stereotaxis, Inc. (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 150,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.

Investor Contacts:                                        
David L. Fischel                                        
Chairman and Chief Executive Officer                        
                                                        
Kimberly Peery                                                
Chief Financial Officer

314-678-6100
[email protected]


Risks

  • Uncertainty in financial performance results could affect stock price volatility after the announcement.
  • Dependence on continued adoption of minimally invasive surgical robotics could impact future growth prospects.
  • Potential competitive pressures in medical robotics and related regulatory or technological challenges.

More from Press Releases

Bank OZK Announces Second Quarter 2026 Earnings Jul 21, 2026 GoHealth Successfully Completes Financial Restructuring and Emerges Well Positioned for Future Success Jul 21, 2026 First Community Bankshares, Inc. Announces Record Second Quarter 2026 Results and Quarterly Cash Dividend Jul 21, 2026 National Bank Holdings Corporation Announces Second Quarter 2026 Financial Results Jul 21, 2026 OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026 Jul 21, 2026